The tissue-array evaluation and/or bioinformatics analysis demonstrated that the elevated expression of Rictor and ABLIM1 in HCC predicts poorer prognosis for HCC patients, implicating them as two promising diagnostic and prognostic indicators for HCC patients. This evidence concerns the gene RICTOR and hepatocellular carcinoma.